Late-breaking Tumor Biology II (posters)

LBF-056

A Novel CCK2/Gastrin Receptor-Localizing Radiolabelled Peptide Probe for Personalized Diagnosis and Therapy of Patients with Progressive or Metastatic Medullary Thyroid Carcinoma - Grant-MCT:  Study Design of a Multicentre First Phase Study
Alicja Hubalewska-D, Paola Anna Erba, Clemens Decristoforo, Renata Mikolajczak, Helmut Maecke, Katja Zaletel, Petra Kolenc-Peitl, Thea Maina-Nock, Irene Virgollini, Agata Jabrocka-Hybel and Monika Tomaszuk

LBF-057

Early Metabolic History Influences Treatment Response to Doxorubicin of Mammary Tumor-Bearing Adult Female Wnt1-Tg Mice
Maria Theresa E Montales, Frank A Simmen, Stepan B Melnyk, Shi Liu, Yunying L Liu and Rosalia CM Simmen

LBF-058

Ectopic Cushing Syndrome: A Diagnostic Dilemma
Sarika Rao, Jennifer Chu and Mira Sofia Tiglao Torres

LBF-059

LBF-060

MEN1 Redefined: A Clinical Comparison of Mutation- Positive and Mutation- Negative Patients with MEN1
Joanne M de Laat, Rob B van der Luijt, Carolina R.C. Pieterman, Maria P Oostveen, Ad RMM Hermus, Olaf M Dekkers, Wouter W. de Herder, Anouk N A Van der Horst-Schrivers, Madeleine L. Drent, Peter H Bisschop, Bastiaan Havekes, Menno R Vriens and Gerlof D Valk

LBF-062

The Affection of TSH on the Papillary Thyroid Cancer Susceptibility of the Variant rs1867277 and rs3758248 in FOXE1
Ling Zhang, Qing-hai Ji, Yong-xue Zhu, Zhuo-ying Wang, Yu Wang and Cai-ping Huang

LBF-063